Glenn Laken

Eric Lefkofsky Indentifies What Needs To Be Fixed In Cancer Research And Helps By Implementing It Into Tempus

Co-Founder Eric Lefkofsky of Tempus Labs has identified that there is a problem with the way the medical field does not have access to molecular data of cancer patients. Tempus Labs ever since startup a little over two years ago has been working towards providing patients and doctors of patients with molecular data. Luckily they have been able to raise the funds to do so and recently were able to raise another 80 million dollars towards more data research to get even further in their journey. With Tempus Labs doing this they make it possible for cancer patients now and in the future to get the right treatment needed for them to overcome cancer.

One of Tempus Labs strengths is that they already have over 4,000 employees to help with not only finding data of cancer patients but they also are able to help answer any questions that any patients might have about anything going on regarding their treatment options or their current treatment plan. Tempus Labs is currently hiring about 30 new people each month but with their ability to raise money over time they plan to start hiring more and more people each month as they see possible. Tempus Lab’s huge team of employees not only can help them always having someone to answer their questions but it can also help patients to feel more comfortable and emotionally understood by employees well going through such a tough time in their life.

Tempus is located in Illinois in the city of Chicago. Not only are they located in a major city with a lot of new technology but they also have partnered with various well-known doctors that specialize in cancer research as well as cancer research facilities such as Mayo Clinic. Tempus labs also has a whole board of scientific advisors who are able to find more and more data over time to help Tempus with their mission in finding better treatment plans for current and future patients.

Tempus labs will continue their cancer data research and raise more and more money towards their research. Tempus will make a difference in the medical world for cancer patients everywhere.

To Know More Click Here

Eric Lefkowsky Highlights The Significance Of Tempus

Eric Lefkofsky is the co-founder of Tempus Labs. He is among the most prominent entrepreneurs in Chicago. Tempus started operations three years ago, and it is at present recognized among the ten top health tech ventures. Tempus Labs has formed a network with the comprehensive centers for cancer across the country. The services it provides includes the following medical imaging, pathology, sequencing of tumors and germline characterization of patients and tumors, RNA sequencing of tumors, liquid biopsy cell-free DNA, and across the board cancer testing.

After its initial inception in 2015, Tempus was able to accumulate donations in the amount of $130 million, and the laboratory currently has a worth of $700 million. Aside from the services given above Tempus is a learning platform machine that analyzes data. It assists doctors in providing a customized care for cancer patients. With the genomic sequencing and molecular therapeutic data analyzation services it gives, doctors are able to make immediate decisions based on the data provided.

The main objective for the creation of Tempus is to be able to administer treatments that were proven effective with prior cancer patients through data. Hence, Tempus will sort the thousands of data collated within its system to have a comprehensible output that medical professionals can use for the remedies and treatment of cancer patients.

Lefkofsky founded and co-established numerous ventures aside from Tempus, and these companies are InnerWorkings, Echo Global Logistics, Uptake Technologies, Mediaocean, and Lightbank. He and his wife Liz are the co-founders of the Lefkofsky Family Foundation – that is mainly involved in education advancements, art and culture (that is related to the general advancement of lives within the communities), medicine, and fundamental rights.

Lately, Tempus was highlighted on the list of Eric Topol, it is an annual feature where Dr. Topol previews technology advances that made it into the news headlines for a year since it assures to mold and transform medicine in the future. Likewise, Tempus Labs has been declared as one of the few innovative technologies. Included are gene editing, gene therapy, bio technologies to be utilized for ailments that have no known cure as for the time being.

To Learn More Click Link :

Professional Management Opportunities At The Cancer Treatment Centers Of America

The Cancer Treatment Centers of America (CTCA) treats at least 4% of the cancer patients within the U.S. The CTCA is a very important organization in the fight against cancer. This organization ensures that patients are receiving the best care possible. They provide the latest care in terms of cures and technology used to fight cancer. They also use cutting edge surgical practices, treatment processes and cancer research to help patients to live longer and more productive lives while they have this disease.

Oncologists are the medical specialists that confront this troublesome disease every day. They are responsible for ensuring that patients are getting the proper treatment that has been tailored made to their situation. While an oncologist’s role in fighting cancer is extremely valuable; there is a need to use management and cancer support staff to help in this process.

Professional Management employment opportunities are available at CTCA hospitals. These individuals work in a variety of positions that help to support treatment centers as a whole. The people who work in these positions offer business support for the hospital. They ensure that patients are provided with the best care during their stay at a CTCA facility and they work closely with CTCA stakeholders to ensure success.

Communication Specialist is one type of management position at the CTCA hospitals. Their job is to communicate the hospital’s benefit to the public and to be a spokesperson for the senior staff members. They also are responsible for video and photo shoots that take place at the CTCA. Social media, radio and television appearances and organizing events for fundraising, research and awareness are all a part of the Communication Specialist’s job description.

The CTCA uses the services of website developers at their organizations to ensure that their internet presence is strong. These individuals will create the hospital’s persona on the web. They also provide the staff members with internet technology to create personalized webpages that coincide with the CTCA goals. Developers monitor the various sites affiliated with the Cancer Treatment Centers of America and they used to perform safeguarding practices that protects the CTCA systems while online.

Jobs such as Employer Engagement Senior Specialist, Manager of Business Services, Mgr, Advocates, Mgr, Pharmacy Operations and Director of Relationship Marketing. Qualified candidates can also apply for available positions that fall under the title of Integration Project Manager, Payor Contracting Manager and Sr Systems Engineer.

Each of these positions play a role with the support that patients and their medical staff need to win the fight against cancer. Each job offers a competitive wage and a very desirable benefits package. Interested candidates can check the Cancer Treatment Centers of America website to find more information about these job postings.

To Learn More Click Here

Dr. Clay Siegal Is Helping Seattle Genetics Develop Effective Treatments For Cancer

Seattle Genetics is a Bothell, Washington-based biotech company that’s best known for developing antibody-based therapies used to treat patients with cancer. The antibody-drug conjugates or ADCs the company created have been hailed as a victory in the fight against cancer. The technology targets cancer cells and destroys them without doing harm to the healthy cells surrounding them. It also reduces the toxic effects caused by traditional cancer treatments. The technology is shared internationally through agreements with GlaxoSmithKline, Genentech, Pfizer and AbbVie and has generated over $300 million for Seattle Genetics.

The moving force behind Seattle Genetics is Dr. Clay Siegal. Trained as a researcher and with many years of experience working on anti-cancer drugs, Dr. Siegal has built Seattle Genetics on a foundation of tireless research, scientific innovation, and product development. The company has a rich development pipeline and through collaboration with other companies has over 20 ADCs in the process of clinical development. Dr. Siegal and the staff at Seattle Genetics are driven to make a difference in the lives of the children and adults forced to live with cancer.

Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors

A graduate of the University of Maryland, Dr. Siegal also has a Ph.D in Genetics from George Washington University. He is widely published and a frequent speaker at scientific conferences. He has worked with companies like Ultragenyx Pharmaceutical,
Mirna Therapeutics, Alder Biopharmaceuticals and many others involved in cancer research. But Dr. Siegal also knows that researching cancer treatment is expensive, so he has undertaken capital raising activities from public and private sources and garnered over $675 million for Seattle Genetics.

Part of the legacy of Dr. Clay Siegal at Seattle Genetics is the focus on innovation through scientific excellence, integrity, team work and mutual respect combined with an entrepreneurial spirit. The result has been groundbreaking new cancer therapies that have the potential to improve the quality of life for millions of people living with cancer. Dr. Clay Siegal has made it his mission to gather the people and resources necessary to go past what is commonly accepted about the treatment of cancer and make inroads towards finding a cure.